NKTR
Nektar Therapeutics · Healthcare
Chief R, D Officer Jonathan Zalevsky sold $31K of Nektar Therapeutics
Sold$31,452
$3.00Price
10,484Shares
−3%Stake
What NKTR did after the filing
- The stock from Tue, Feb 21 open, $45.45
- −77.2%
- S&P 500, same days
- +1.8%
Measured over 30 trading days, to the Apr 4 close.
Traded Thu, Feb 16. Filed Fri, Feb 17, 4:00 PM ET, after the close. Returns use the Feb 21 open and the Apr 4 close. Not investment advice.